Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV001169970 | SCV001251684 | pathogenic | Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001593305 | SCV001814360 | pathogenic | not provided | 2021-01-05 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Has not been previously published as pathogenic or benign to our knowledge |
Solve- |
RCV004768886 | SCV005091484 | likely pathogenic | Autosomal recessive ataxia, Beauce type | 2022-06-01 | no assertion criteria provided | provider interpretation | Variant confirmed as disease-causing by referring clinical team |